Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Imraldi Patient Alert Card

This card contains select important safety information that patients need to know before and during treatment with Imraldi.

Imraldi Safety Brochure

The purpose of this safety monograph is to inform physicians and other HCPs about the key safety risks associated with the use of TNF antagonists such as adalimumab (IMRALDI®), and to help HCPs in screening and monitoring patients appropriately while they are receiving TNF antagonist therapy.

For Healthcare Professionals

Imraldi TB Brochure

TUBERCULOSIS (TB) SCREENING BEFORE INITIATING ANTI-TNF THERAPY - A RESOURCE GUIDE FOR HCPs

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.